Literature DB >> 14659508

Changes in temporomandibular pain and other symptoms across the menstrual cycle.

Linda LeResche1, Lloyd Mancl, Jeffrey J Sherman, Beatrice Gandara, Samuel F Dworkin.   

Abstract

The objective of this study was to assess changes in levels of clinical temporomandibular (TMD) pain in relation to phases of the menstrual cycle. TMD cases were 35 women not using oral contraceptives (OCs); 35 women using OCs; and 21 men. Controls were 35 normally cycling women without TMD or other chronic pains. Subjects kept daily diaries over three menstrual cycles, reporting average and worst pain, general and premenstrual symptoms. Data were subject-centered and de-trended using the residuals from a random-effects linear regression model. To test for cyclic variation, cycles were standardized to 28 days and data were grouped into 9 periods/cycle (Days 1-3, 4-6, em leader, 22-24, 25-28). Overall levels of average pain, worst pain and symptoms did not differ across TMD subject groups. For worst pain, multivariate analysis of variance revealed a statistically significant difference across 3-day periods for normally cycling women with TMD (P=0.011) and for women using OCs (P=0.017). In both groups, TMD pain levels rose toward the end of the cycle and peaked during menstruation. In women not using OCs, there was a secondary pain peak at Days 13-15, around the time of ovulation. This peak was not seen in women using OCs. There was no statistically significant difference over time periods for men (P=0.94). Similar patterns were found for average pain, as well as PMS symptoms and general somatic symptoms. These results suggest that TMD pain in women is highest at times of lowest estrogen, but rapid estrogen change may also be associated with increased pain.

Entities:  

Mesh:

Year:  2003        PMID: 14659508     DOI: 10.1016/j.pain.2003.06.001

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  86 in total

1.  Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Richard Ohrbach; Roger B Fillingim; Flora Mulkey; Yoly Gonzalez; Sharon Gordon; Henry Gremillion; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Joel D Greenspan; Charles Knott; William Maixner; Gary Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Influence of oral contraceptives on endogenous pain control in healthy women.

Authors:  Taraneh Rezaii; Malin Ernberg
Journal:  Exp Brain Res       Date:  2010-04-24       Impact factor: 1.972

Review 3.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

4.  Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.

Authors:  Yolanda R Smith; Christian S Stohler; Thomas E Nichols; Joshua A Bueller; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

5.  Genes in the GABA Pathway Increase in the Lateral Thalamus of Sprague-Dawley Rats During the Proestrus/Estrus Phase.

Authors:  Mikhail Umorin; Crystal Stinson; Larry L Bellinger; Phillip R Kramer
Journal:  J Cell Physiol       Date:  2015-09-30       Impact factor: 6.384

6.  Orthodontic Treatment, Genetic Factors and Risk of Temporomandibular Disorder.

Authors:  Gary D Slade; Luda Diatchenko; Richard Ohrbach; William Maixner
Journal:  Semin Orthod       Date:  2008-06       Impact factor: 0.970

7.  Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans.

Authors:  Helle Andersen; Lars Arendt-Nielsen; Peter Svensson; Bente Danneskiold-Samsøe; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2008-09-24       Impact factor: 1.972

8.  Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.

Authors:  N Lynn Henry; Anna Conlon; Kelley M Kidwell; Kent Griffith; Jeffrey B Smerage; Anne F Schott; Daniel F Hayes; David A Williams; Daniel J Clauw; Steven E Harte
Journal:  J Pain       Date:  2014-01-22       Impact factor: 5.820

9.  Acute HPA axis response to naltrexone differs in female vs. male smokers.

Authors:  Daniel J O Roche; Emma Childs; Alyssa M Epstein; Andrea C King
Journal:  Psychoneuroendocrinology       Date:  2009-10-17       Impact factor: 4.905

10.  Chronic inflammation and estradiol interact through MAPK activation to affect TMJ nociceptive processing by trigeminal caudalis neurons.

Authors:  A Tashiro; K Okamoto; D A Bereiter
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.